Broadridge’s LTX looks to GenAI as it competes for market share

LTX has pinned its hopes of breaking into the fixed-income market on innovative use of AI. But how successful has its approach been, and what is it up against?

Breaking into a market where giants already loom large isn’t for the faint of heart, nor the shallow of pockets. In fixed-income trading platforms, there are the Big Three: Bloomberg, MarketAxess, and Tradeweb. But two years ago, Broadridge ambitiously threw its hat into the bond trading ring with its LTX platform.

LTX’s value proposition is that broker-dealers stand to gain better execution and price improvement by aggregating liquidity across multiple buyers. It offers an AI-powered trading

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

This address will be used to create your account

A tech revolution in an old-school industry: FX

FX is in a state of transition, as asset managers and financial firms explore modernizing their operating processes. But manual processes persist. MillTechFX’s Eric Huttman makes the case for doubling down on new technology and embracing automation to increase operational efficiency in FX.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here